High-dose vaccine protects seniors against flu-related hospitalization

A study published in Vaccine examined whether administering high-dose influenza vaccine to seniors could prevent their being hospitalized for flu-related reasons.

Advertisement

Researchers used a nested series of models across matching strata to determine the vaccine effectiveness for the high-dose vaccine in preventing flu-related hospital stays during the 2016-17 flu season in the Portland, Ore., metropolitan area.

Researchers studied 23,712 matched pairs of high-dose to standard-dose vaccinated seniors. They found the high-dose vaccine was 30.7 percent more effective at preventing flu-related hospitalizations than the standard-dose vaccines.

“For this study, the high-dose influenza vaccine provided superior protection for seniors against influenza hospitalization,” study authors concluded.

More articles on healthcare quality: 
Where are the 5-star VA hospitals?
VA hospital star rankings: 1-star hospitals drop from 14 to 9 in 2018
EEOC sues Saint Thomas Health over mandatory flu shot policy

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.